Janux Therapeutics Inc

NASDAQ:JANX   4:00:00 PM EDT
23.10
-0.05 (-0.22%)
7:43:25 PM EDT: $24.00 +0.90 (+3.90%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.37B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.27 Million
Adjusted EPS-$0.46
See more estimates
10-Day MA$23.50
50-Day MA$26.17
200-Day MA$39.66
See more pivots

Janux Therapeutics Inc Stock, NASDAQ:JANX

10955 Vista Sorrento Parkway, Suite 200, San Diego, California 92130
United States of America
Phone: +1.858.751.4493
Number of Employees: 81
http://www.januxrx.com

Description

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in San Diego, CA.